Literature DB >> 14066634

NEUROPATHOLOGICAL AND NEUROCHEMICAL ASPECTS OF GENERALIZED GLYCOGEN STORAGE DISEASE.

L CROME, J N CUMINGS, S DUCKETT.   

Abstract

Keywords:  BRAIN; CEREBROSIDES; CHOLESTEROL; ELECTROENCEPHALOGRAPHY; GLYCOGEN; GLYCOGENOSIS; HEXOSAMINES; HISTOCYTOCHEMISTRY; INFANT; LIPIDS; LIVER FUNCTION; MYOCARDIUM; NEURAMINIC ACIDS; PATHOLOGY; PHOSPHOLIPIDS; SPLEEN; WATER

Mesh:

Substances:

Year:  1963        PMID: 14066634      PMCID: PMC495611          DOI: 10.1136/jnnp.26.5.422

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  10 in total

1.  Generalized glycogenosis.

Authors:  H STOECKLE; A S GOLDMAN; J A WEBB
Journal:  Am J Cardiol       Date:  1961-11       Impact factor: 2.778

2.  Observations on generalized glycogenosis with emphasis on electrocardiographic changes.

Authors:  J L CADDELL; R WHITTEMORE
Journal:  Pediatrics       Date:  1962-05       Impact factor: 7.124

3.  Glycogen-storage disease. Report of a case with generalized glycogenosis and review of the literature.

Authors:  O F MULLER; S BELLET; A ERTRUGRUL
Journal:  Circulation       Date:  1961-02       Impact factor: 29.690

4.  Determination of neuraminic acid in crude brain lipids.

Authors:  C LONG; D A STAPLES
Journal:  Biochem J       Date:  1959-11       Impact factor: 3.857

5.  [Cardiac glycogenosis. Anatomical presentation of 2 cases].

Authors:  C JEAN; G MILLER
Journal:  Laval Med       Date:  1960-04

6.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

7.  [The glucagon problem in glycogenosis].

Authors:  R GITZELMANN
Journal:  Helv Paediatr Acta       Date:  1957-10

8.  The cerebral lipids in disseminated sclerosis and in amaurotic family idiocy.

Authors:  J N CUMINGS
Journal:  Brain       Date:  1953       Impact factor: 13.501

9.  [Infantile glycogenosis simulating a fatal progressive cerebrospinal affection].

Authors:  W SELBERG
Journal:  Z Kinderheilkd       Date:  1953

10.  Glycogen disease resembling mongolism, cretinism, and amytonia congenita; case report and review of literature.

Authors:  D H CLEMENT; G C GODMAN
Journal:  J Pediatr       Date:  1950-01       Impact factor: 4.406

  10 in total
  7 in total

1.  [On the storage of mucopolysaccharide-like substances in the brain in generalized glycogenosis (type II)].

Authors:  R Schnabel
Journal:  Acta Neuropathol       Date:  1965-07-01       Impact factor: 17.088

2.  Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle.

Authors:  J J Martin; T de Barsy; F van Hoof; G Palladini
Journal:  Acta Neuropathol       Date:  1973-02-19       Impact factor: 17.088

3.  [Histochemistry of mucopolysaccharide-like substances (basophilic substances) in skeletal muscle in neuromuscular glycogenosis (type II)].

Authors:  R Schnabel
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

4.  CRIM-negative infantile Pompe disease: 42-month treatment outcome.

Authors:  Marianne Rohrbach; Andrea Klein; Alice Köhli-Wiesner; Dorothe Veraguth; Ianina Scheer; Christian Balmer; Roger Lauener; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

5.  Generalized glycogenosis type II (Pompe's disease).

Authors:  M R Nihill; D S Wilson; K Hugh-Jones
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

6.  Myopathies due to enzyme deficiencies.

Authors:  F Cornelio; S Di Donato
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

7.  Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

Authors:  Richard L Sidman; Tatyana Taksir; Jonathan Fidler; Michael Zhao; James C Dodge; Marco A Passini; Nina Raben; Beth L Thurberg; Seng H Cheng; Lamya S Shihabuddin
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.